- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Revlimid (lenalidomide)
Total 1058 results
-
Landspitali University HospitalMemorial Sloan Kettering Cancer Center; Celgene; Amgen; University of IcelandEnrolling by invitationMultiple Myeloma | Smoldering Multiple MyelomaIceland
-
Massachusetts General HospitalCompletedMultiple MyelomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B Chronic Lymphocytic LeukemiaUnited States
-
King Faisal Specialist Hospital & Research CenterCompleted
-
Zhao WeiliNot yet recruitingDiffuse Large B-cell LymphomaChina
-
Irene Ghobrial, MDJanssen Research & Development, LLCRecruitingMultiple Myeloma | Smoldering Multiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
David Bond, MDBristol-Myers SquibbActive, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent... and other conditionsUnited States
-
The Lymphoma Academic Research OrganisationCelgene CorporationActive, not recruitingFollicular LymphomaSpain, Canada, France, Australia, Italy, Belgium, Germany, Portugal
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; China Medical University Hospital; Chang... and other collaboratorsNot yet recruitingPeripheral T-cell Lymphomas (PTCL)Taiwan
-
Sun Yat-sen UniversityRecruitingRelapsed or Refractory Peripheral T-cell LymphomaChina
-
Abramson Cancer Center at Penn MedicineCompletedFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle-Cell Lymphoma | Lymphoma, Small Lymphocytic | Marginal Zone B-Cell Lymphoma | MALT Lymphoma | Lymphoma of Mucosa-Associated Lymphoid TissueUnited States
-
Case Comprehensive Cancer CenterTerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
M.D. Anderson Cancer CenterSanofiRecruitingMultiple MyelomaUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.Recruiting
-
Peking Union Medical College HospitalRecruiting
-
Seoul National University HospitalRecruitingRelapsed/Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, Germany
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
St. Joseph's Hospital and Medical Center, PhoenixTexas Tech UniversityNot yet recruitingCognitive Dysfunction | Neurodegenerative Disease, Hereditary | Cognitive Impairment, Mild | Amyloid Plaque | Inflammation, Brain
-
MorphoSys AGCompletedDiffuse Large B-cell LymphomaBelgium, Germany, United States, Austria, Czechia, France, Italy, Portugal, Spain
-
Innate PharmaCompletedPatients With Multiple Myeloma Experiencing a | First or Second RelapseUnited States
-
University of RochesterRecruitingMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityAstraZeneca; Celgene CorporationActive, not recruitingMantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedMultiple MyelomaUnited States
-
The Lymphoma Academic Research OrganisationCelgene CorporationCompletedRelapsed/Refractory B-cell LymphomaFrance
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
SanofiCompleted
-
National Cancer Institute (NCI)Active, not recruitingAnemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | de Novo Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory... and other conditionsUnited States
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States, Canada
-
Bristol-Myers SquibbExelixisCompletedAdvanced Cancer, Various, NOSUnited States
-
Yale UniversityCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLC; AmgenCompletedMultiple MyelomaUnited States
-
University of AthensHellenic Cooperative Oncology GroupCompleted
-
Massachusetts General HospitalSanofi; AmgenActive, not recruiting
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Celgene; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsCompletedSmoldering Multiple Myeloma | Smoldering MyelomaUnited States
-
University of Heidelberg Medical CenterCompleted
-
Yvonne EfeberaBristol-Myers Squibb; National Cancer Institute (NCI); American Cancer Society...TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; AmgenUnknown
-
National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Novartis PharmaceuticalsBristol-Myers SquibbRecruitingNon-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone LymphomaUnited States, Germany, Italy, Korea, Republic of, Spain, Singapore, China, Japan, Australia
-
Beijing Friendship HospitalRecruiting
-
The Lymphoma Academic Research OrganisationCentre Henri BecquerelCompletedFollicular LymphomaFrance
-
Washington University School of MedicineKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Myeloma-Associated AmyloidosisUnited States